111 related articles for article (PubMed ID: 19619437)
21. Characterization and antitumor activity of pollen polysaccharide.
Yang X; Guo D; Zhang J; Wu M
Int Immunopharmacol; 2007 Apr; 7(4):427-34. PubMed ID: 17321465
[TBL] [Abstract][Full Text] [Related]
22. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice.
Zhu XL; Chen AF; Lin ZB
J Ethnopharmacol; 2007 May; 111(2):219-26. PubMed ID: 17182202
[TBL] [Abstract][Full Text] [Related]
23. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.
Man S; Bocci G; Francia G; Green SK; Jothy S; Hanahan D; Bohlen P; Hicklin DJ; Bergers G; Kerbel RS
Cancer Res; 2002 May; 62(10):2731-5. PubMed ID: 12019144
[TBL] [Abstract][Full Text] [Related]
24. [Antitumor effects of raddeanin A on S180, H22 and U14 cell xenografts in mice].
Wang MK; Ding LS; Wu FE
Ai Zheng; 2008 Sep; 27(9):910-3. PubMed ID: 18799026
[TBL] [Abstract][Full Text] [Related]
25. Synergistic immunostimulatory effect of pidotimod and red ginseng acidic polysaccharide on humoral immunity of immunosuppressed mice.
Du Xiao F; Jiang CZ; Wu CF; Won EK; Choung SY
Pharmazie; 2008 Dec; 63(12):904-8. PubMed ID: 19177908
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of cyclophosphamide-induced antitumor effect by a novel polysaccharide from Ganoderma atrum in sarcoma 180-bearing mice.
Li W; Nie S; Chen Y; Wang Y; Li C; Xie M
J Agric Food Chem; 2011 Apr; 59(8):3707-16. PubMed ID: 21381781
[TBL] [Abstract][Full Text] [Related]
27. Low dose radiation increased the therapeutic efficacy of cyclophosphamide on S(180) sarcoma bearing mice.
Yu HS; Xue HW; Guo CB; Song AQ; Shen FZ; Liang J; Deng C
J Radiat Res; 2007 Jul; 48(4):281-8. PubMed ID: 17548941
[TBL] [Abstract][Full Text] [Related]
28. [Effects of abalong polysaccharide on the activity of the peritoneal macrophages and delayed-type hypersensitivity in mice bearing S180].
Xu D; Wang B; Xu S; Ling Y; Shao Z
Zhong Yao Cai; 1999 Feb; 22(2):88-9. PubMed ID: 12575051
[TBL] [Abstract][Full Text] [Related]
29. The antitumor and immunostimulating activities of water soluble polysaccharides from Radix Aconiti, Radix Aconiti Lateralis and Radix Aconiti Kusnezoffii.
Gao T; Bi H; Ma S; Lu J
Nat Prod Commun; 2010 Mar; 5(3):447-55. PubMed ID: 20420326
[TBL] [Abstract][Full Text] [Related]
30. Preparation of a chemically sulfated polysaccharide derived from Grifola frondosa and its potential biological activities.
Nie X; Shi B; Ding Y; Tao W
Int J Biol Macromol; 2006 Nov; 39(4-5):228-33. PubMed ID: 16822541
[TBL] [Abstract][Full Text] [Related]
31. Optimized Animal Model of Cyclophosphamide-induced Bone Marrow Suppression.
Feng L; Huang Q; Huang Z; Li H; Qi X; Wang Y; Liu Z; Liu X; Lu L
Basic Clin Pharmacol Toxicol; 2016 Nov; 119(5):428-435. PubMed ID: 27061017
[TBL] [Abstract][Full Text] [Related]
32. Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy.
Yamauchi K; Yang M; Hayashi K; Jiang P; Yamamoto N; Tsuchiya H; Tomita K; Moossa AR; Bouvet M; Hoffman RM
Cancer Res; 2008 Jan; 68(2):516-20. PubMed ID: 18199547
[TBL] [Abstract][Full Text] [Related]
33. [Inhibitory effect of combined bacterin on growth of sarcoma 180 in mice].
Li SM; Luo XT; Ye JH; Xiong YL; Yu L; Zhong FY; Huang Q
Ai Zheng; 2007 Apr; 26(4):382-5. PubMed ID: 17430656
[TBL] [Abstract][Full Text] [Related]
34. Immunomodulation and antitumor activity of kappa-carrageenan oligosaccharides.
Yuan H; Song J; Li X; Li N; Dai J
Cancer Lett; 2006 Nov; 243(2):228-34. PubMed ID: 16410037
[TBL] [Abstract][Full Text] [Related]
35. The influence of endotoxin on transplantates of Crocker sarcoma and behavior of the thymus in mice.
Turowski G; Kobielowa Z
Arch Immunol Ther Exp (Warsz); 1969; 17(5):584-9. PubMed ID: 4905497
[No Abstract] [Full Text] [Related]
36. [Combined therapy of experimental tumors with the vaccinal strain of Venezulean encephalomyelitis virus].
Urazova LN; Gromova AI
Vopr Onkol; 2001; 47(1):78-80. PubMed ID: 11317543
[TBL] [Abstract][Full Text] [Related]
37. In vivo effects of cyclophosphamide on oncogene and suppressor gene expression in a "follow up" study.
Ember I; Kiss I
Anticancer Res; 1997; 17(5A):3593-7. PubMed ID: 9413208
[TBL] [Abstract][Full Text] [Related]
38. Reduction of hematotoxicity and augmentation of antitumor efficacy of cyclophosphamide by dopamine.
Lakshmi C; Deb C; Ray C; Ray MR
Neoplasma; 2005; 52(1):68-73. PubMed ID: 15739030
[TBL] [Abstract][Full Text] [Related]
39. Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular-mass tumor-associated antigens: the bone marrow and thymus.
Ben-Hur H; Kossoy G; Kossoy N; Zusman I
Int J Mol Med; 2002 Oct; 10(4):517-21. PubMed ID: 12239604
[TBL] [Abstract][Full Text] [Related]
40. A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens.
Emmenegger U; Man S; Shaked Y; Francia G; Wong JW; Hicklin DJ; Kerbel RS
Cancer Res; 2004 Jun; 64(11):3994-4000. PubMed ID: 15173013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
